GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

More than 800 million adults have diabetes worldwide, almost twice as many as previously thought, research has suggested.

November is Diabetes Awareness Month and an eye care specialist in Preston has issued an important reminder to all diabetics.

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

The serious health condition affected around 14 percent of all adults worldwide in 2022, compared to seven percent in 1990, ...

LONDON – Global diabetes rate in adults has doubled over the past three decades, impacting more than 800 million people ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Shocking statistics reveal the rapid rise of diabetes worldwide. Uncover the challenges facing millions and the urgent need ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

The percentage of adults suffering from diabetes across the world has doubled over the past three decades, a study said ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...